Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER studyClaudio Bonifati, Giuseppe Argenziano, Concetta Potenza et al.|Journal of the European Academy of Dermatology and Venereology|2024Cited by 10
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyC. Bonifati, Antonio Costanzo, G. Argenziano et al.|Journal of Dermatological Treatment|2026Cited by 1
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyClaudio Bonifati, Antonio Costanzo, Giuseppe Argenziano et al.|Open MIND|2026Cited by 0
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER studyClaudio Bonifati, Antonio Costanzo, Federico Saibene et al.|Figshare|2026Cited by 0